Glucagon-like peptide-1 drugs, gastrointestinal function and critical illness

Current Opinion in Critical Care · Published 2026-03-05 · DOI 10.1097/mcc.0000000000001376

Authors being retrieved — see the publisher record. https://doi.org/10.1097/mcc.0000000000001376

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Strategies for improving recovery of consciousness after acute brain injury · Current Opinion in Critical Care · 2026 · Same journal
• Personalized protein delivery in critical care: from phenotyping and endotyping to post-ICU recovery · Current Opinion in Critical Care · 2026 · Same journal
• Advances in the postoperative care of the liver transplant recipient · Current Opinion in Critical Care · 2026 · Same journal
• How to establish and run a national ICU benchmarking registry · Current Opinion in Critical Care · 2026 · Same journal
• Current evidence on septic shock in patients with cirrhosis · Current Opinion in Critical Care · 2026 · Same journal
• Preexisting malnutrition in the ICU · Current Opinion in Critical Care · 2026 · Same journal
• Ventilator-associated pneumonia: newer insights that can drive improved outcomes · Current Opinion in Critical Care · 2026 · Same journal
• Antibiotic use in serious infections · Current Opinion in Critical Care · 2026 · Same journal
• Acalculous cholecystitis in the critically ill: evolving insights into diagnosis and management · Current Opinion in Critical Care · 2026 · Same journal
• Recent advances and trends in critical care of neuro-infectious disease · Current Opinion in Critical Care · 2026 · Same journal